In rare diseases like Thyroid Eye Disease (TED), collaboration between patient advocacy groups and research is crucial to progress, ensuring patient needs and voices are reflected through the whole clinical trial process. This is widely recognized in 2024. Our mission since 2015 has not only been to make advocacy an integral part of the research ecosystem, but to make partnerships with them truly reciprocal. By ensuring authenticity and reciprocity is at the core of the collaboration, we’re creating lasting partnerships that strengthen their ability to support their patient communities.
In the TED space, patient advocacy groups (such as TED Community Organization) play a crucial role in providing a bridge between patients and research. These groups offer valuable insights into the patient experience, including the daily challenges, concerns, and priorities of those living with TED. By tapping into this firsthand knowledge, research sponsors can better design and execute clinical trials that are more patient-centered, improving recruitment, retention, and ultimately, outcomes. For instance, sponsors might adjust trial protocols to address patient concerns about treatment side effects or logistical challenges in attending clinical visits.
Conversely, these partnerships also benefit patient advocacy groups. They can gain access to the latest developments in TED research, including emerging potential therapies and treatment advancements. This empowers the groups to keep their communities informed about clinical trials and new potential treatment options, allowing patients to make informed decisions about their care. Moreover, the connection to research sponsors helps advocacy groups advocate for more accessible and timely treatments for their members.
However, as there are fewer groups in a rare disease space like TED, groups often have to navigate a high volume of communications from the research world, investing a lot of time in helping drive research forward. This makes truly reciprocal partnerships even more critical, giving back in ways tailored to the needs of each group. This can include offering clinical trial education initiatives to break down the typical clinical trial experience, which is a system that can be difficult to understand [and initially a little scary!] for patients. We’ve even helped support advocacy groups’ efforts to increase their social media reach, helping scale their impact. These tailored ways of giving back are especially impactful for growing, grassroots advocacy groups.
If you take one thing away, it’s that showing up in a truly authentic way to learn the unique needs and vision of each advocacy group fosters longevity in these partnerships. We can help them level up in ways they determine, while they support research in putting the patient voice at the center, leading to medical breakthroughs.
Leave a Reply